Junzo Watanabe

660 total citations
31 papers, 466 citations indexed

About

Junzo Watanabe is a scholar working on Psychiatry and Mental health, Molecular Biology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Junzo Watanabe has authored 31 papers receiving a total of 466 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Psychiatry and Mental health, 7 papers in Molecular Biology and 7 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Junzo Watanabe's work include Schizophrenia research and treatment (15 papers), Cardiac electrophysiology and arrhythmias (6 papers) and Diet and metabolism studies (5 papers). Junzo Watanabe is often cited by papers focused on Schizophrenia research and treatment (15 papers), Cardiac electrophysiology and arrhythmias (6 papers) and Diet and metabolism studies (5 papers). Junzo Watanabe collaborates with scholars based in Japan and Canada. Junzo Watanabe's co-authors include Toshiyuki Someya, Naoki Fukui, Yutaro Suzuki, Takuro Sugai, Shin Ono, Nobuto Tsuneyama, Yoshimasa Inoue, Mami Saito, Kazushi Sawamura and Vural Özdemir and has published in prestigious journals such as PLoS ONE, Psychiatry Research and Schizophrenia Research.

In The Last Decade

Junzo Watanabe

31 papers receiving 459 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Junzo Watanabe Japan 15 203 112 97 78 65 31 466
Nobuto Tsuneyama Japan 12 161 0.8× 62 0.6× 84 0.9× 39 0.5× 73 1.1× 29 335
Petra Vinken Belgium 13 103 0.5× 223 2.0× 37 0.4× 41 0.5× 122 1.9× 31 663
Niclas Lunder Norway 7 133 0.7× 96 0.9× 23 0.2× 36 0.5× 62 1.0× 10 355
Čedo Miljević Serbia 12 146 0.7× 109 1.0× 21 0.2× 70 0.9× 23 0.4× 41 488
Chiaki Kawanishi Japan 11 129 0.6× 80 0.7× 43 0.4× 121 1.6× 16 0.2× 19 333
Kazushi Sawamura Japan 10 128 0.6× 117 1.0× 17 0.2× 83 1.1× 28 0.4× 15 374
Shingo Ono Japan 13 270 1.3× 53 0.5× 32 0.3× 116 1.5× 28 0.4× 39 494
Frederik Vandenberghe Switzerland 10 148 0.7× 32 0.3× 29 0.3× 39 0.5× 60 0.9× 33 302
S A Volpicelli United States 8 447 2.2× 143 1.3× 27 0.3× 94 1.2× 16 0.2× 8 790
Niko Seppälä Finland 12 251 1.2× 55 0.5× 18 0.2× 33 0.4× 30 0.5× 20 398

Countries citing papers authored by Junzo Watanabe

Since Specialization
Citations

This map shows the geographic impact of Junzo Watanabe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junzo Watanabe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junzo Watanabe more than expected).

Fields of papers citing papers by Junzo Watanabe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Junzo Watanabe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junzo Watanabe. The network helps show where Junzo Watanabe may publish in the future.

Co-authorship network of co-authors of Junzo Watanabe

This figure shows the co-authorship network connecting the top 25 collaborators of Junzo Watanabe. A scholar is included among the top collaborators of Junzo Watanabe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Junzo Watanabe. Junzo Watanabe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tsuneyama, Nobuto, Yutaro Suzuki, Kazushi Sawamura, et al.. (2016). Effect of Serum Leptin on Weight Gain Induced by Olanzapine in Female Patients with Schizophrenia. PLoS ONE. 11(3). e0149518–e0149518. 11 indexed citations
2.
Fukui, Naoki, Yutaro Suzuki, Takuro Sugai, et al.. (2014). Promoter variation in the catechol-O-methyltransferase gene is associated with remission of symptoms during fluvoxamine treatment for major depression. Psychiatry Research. 218(3). 353–355. 6 indexed citations
3.
Suzuki, Yutaro, Takuro Sugai, Shin Ono, et al.. (2014). Changes in PR and QTc intervals after switching from olanzapine to risperidone in patients with stable schizophrenia. Psychiatry and Clinical Neurosciences. 68(5). 353–356. 6 indexed citations
4.
Suzuki, Yutaro, Takuro Sugai, Naoki Fukui, et al.. (2013). Differences in plasma prolactin levels in patients with schizophrenia treated on monotherapy with five second-generation antipsychotics. Schizophrenia Research. 145(1-3). 116–119. 15 indexed citations
5.
Suzuki, Yutaro, Nobuto Tsuneyama, Naoki Fukui, et al.. (2013). Impact of the ABCB1 Gene Polymorphism on Plasma 9-Hydroxyrisperidone and Active Moiety Levels in Japanese Patients With Schizophrenia. Journal of Clinical Psychopharmacology. 33(3). 411–414. 21 indexed citations
6.
Ono, Shin, Yutaro Suzuki, Naoki Fukui, et al.. (2013). The Prevalence of Glucose Intolerance in Japanese Schizophrenic Patients With a Normal Fasting Glucose Level. Journal of Clinical Psychopharmacology. 33(4). 525–527. 4 indexed citations
7.
Suzuki, Yutaro, Takuro Sugai, Naoki Fukui, et al.. (2013). Sex differences in the effect of four second‐generation antipsychotics on QTc interval in patients with schizophrenia. Human Psychopharmacology Clinical and Experimental. 28(3). 215–219. 15 indexed citations
8.
Sugai, Takuro, Yutaro Suzuki, Naoki Fukui, et al.. (2012). Excessive Insulin Secretion in Japanese Schizophrenic Patients Treated With Antipsychotics Despite Normal Fasting Glucose Levels. Journal of Clinical Psychopharmacology. 32(6). 750–755. 5 indexed citations
9.
Watanabe, Junzo, Yutaro Suzuki, & Toshiyuki Someya. (2012). Lipid Effects of Psychiatric Medications. Current Atherosclerosis Reports. 15(1). 292–292. 3 indexed citations
10.
Suzuki, Yutaro, Takuro Sugai, Naoki Fukui, et al.. (2012). Changes in QT interval after switching to quetiapine in Japanese patients with schizophrenia. Human Psychopharmacology Clinical and Experimental. 28(1). 94–96. 3 indexed citations
11.
Watanabe, Junzo, Yutaro Suzuki, Takuro Sugai, et al.. (2012). The lipid profiles in Japanese patients with schizophrenia treated with antipsychotic agents. General Hospital Psychiatry. 34(5). 525–528. 8 indexed citations
12.
Watanabe, Junzo, Yutaro Suzuki, Naoki Fukui, et al.. (2011). Increased Risk of Antipsychotic-Related QT Prolongation During Nighttime. Journal of Clinical Psychopharmacology. 32(1). 18–22. 22 indexed citations
13.
Ono, Shin, Yutaro Suzuki, Naoki Fukui, et al.. (2011). Association between the GIPR gene and the insulin level after glucose loading in schizophrenia patients treated with olanzapine. The Pharmacogenomics Journal. 12(6). 507–512. 9 indexed citations
14.
Suzuki, Yutaro, Naoki Fukui, Junzo Watanabe, et al.. (2010). Gender differences in the relationship between the risperidone metabolism and the plasma prolactin levels in psychiatric patients. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 34(7). 1266–1268. 14 indexed citations
15.
Suzuki, Yutaro, Kazushi Sawamura, Shin Ono, et al.. (2010). The wide variability of perospirone metabolism and the effect of perospirone on prolactin in psychiatric patients. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 34(6). 830–833. 4 indexed citations
16.
Takahashi, Makoto, Hiroshi Hayashi, Yuichiro Watanabe, et al.. (2010). Diagnostic classification of schizophrenia by neural network analysis of blood-based gene expression signatures. Schizophrenia Research. 119(1-3). 210–218. 67 indexed citations
17.
Suzuki, Yutaro, Junzo Watanabe, Naoki Fukui, Vural Özdemir, & Toshiyuki Someya. (2009). Hypoglycaemia induced by second generation antipsychotic agents in schizophrenic non-diabetic patients. BMJ. 338(may26 3). a1792–a1792. 10 indexed citations
18.
Watanabe, Junzo, Yutaro Suzuki, Naoki Fukui, et al.. (2008). Dose-Dependent Effect of the CYP2D6 Genotype on the Steady-state Fluvoxamine Concentration. Therapeutic Drug Monitoring. 30(6). 705–708. 18 indexed citations
19.
Suzuki, Yutaro, Naoki Fukui, Kazushi Sawamura, et al.. (2008). Concentration-Response Relationship for Fluvoxamine Using Remission as an Endpoint. Journal of Clinical Psychopharmacology. 28(3). 325–328. 10 indexed citations
20.
Fukui, Naoki, Yutaro Suzuki, Kazushi Sawamura, et al.. (2007). Dose-Dependent Effects of the 3435 C>T Genotype of ABCB1 Gene on the Steady-State Plasma Concentration of Fluvoxamine in Psychiatric Patients. Therapeutic Drug Monitoring. 29(2). 185–189. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nobuto Tsuneyama Breakdown of academic impact, for papers by Petra Vinken Breakdown of academic impact, for papers by Niclas Lunder Breakdown of academic impact, for papers by Čedo Miljević Breakdown of academic impact, for papers by Chiaki Kawanishi Breakdown of academic impact, for papers by Kazushi Sawamura Breakdown of academic impact, for papers by Shingo Ono Breakdown of academic impact, for papers by Frederik Vandenberghe Breakdown of academic impact, for papers by S A Volpicelli Breakdown of academic impact, for papers by Niko Seppälä
Rankless by CCL
2026